Glaukos Corp logo

Glaukos Corp

$ 54.14 +0.61 (+1.14%) 02:45 PM EST
P/E:
At Loss
P/B:
4.64
Market Cap:
$ 2.65B
Enterprise V:
$ 2.50B
Volume:
229.86K
Avg Vol (2M):
647.99K
Also Trade In:
Volume:
229.86K
Market Cap $:
2.65B
PE Ratio:
At Loss
Avg Vol (2-Month):
647.99K
Enterprise Value $:
2.50B
PB Ratio:
4.64
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Name Current Vs Industry Vs History
Cash-To-Debt 1.02
Equity-to-Asset 0.55
Debt-to-Equity 0.68
Debt-to-EBITDA -55.34
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.32
Distress
Grey
Safe
Beneish M-Score -3.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.77
9-Day RSI 51.34
14-Day RSI 51.6
6-1 Month Momentum % -16.88
12-1 Month Momentum % -1.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.78
Quick Ratio 6.38
Cash Ratio 5.63
Days Inventory 122.64
Days Sales Outstanding 44.84
Days Payable 56.59

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.2

Financials (Next Earnings Date:2022-11-04 Est.)

GKOS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:GKOS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 288.316
EPS (TTM) ($) -1.19
Beta 1.25
Volatility % 46.06
14-Day RSI 51.6
14-Day ATR ($) 2.449671
20-Day SMA ($) 54.057
12-1 Month Momentum % -1.62
52-Week Range ($) 33.33 - 64.49
Shares Outstanding (Mil) 47.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Glaukos Corp Filings

Document Form Filing Date
No Filing Data

Glaukos Corp Analysis

Share your research

Headlines

See More
No news.